Features of MRI of the prostate gland when planning targeted biopsy with combined ultrasound and magnetic resonance imaging control

Capa

Citar

Texto integral

Resumo

.

Sobre autores

A. Burulev

North-Western State Medical University named after I.I. Mechnikov

Autor responsável pela correspondência
Email: artmed@mail.ru
Rússia, 41, Kirochnaya street, Saint Petersburg, 191015

I. Itskovich

North-Western State Medical University named after I.I. Mechnikov

Email: artmed@mail.ru
Rússia, 41, Kirochnaya street, Saint Petersburg, 191015

M. Kakheli

North-Western State Medical University named after I.I. Mechnikov

Email: artmed@mail.ru
Rússia, 41, Kirochnaya street, Saint Petersburg, 191015

Bibliografia

  1. Zyryanov AV, Popov IB, Ponomarev AV, et al. Targeted prostate biopsy under MRI control (fusion). Academic journal of West Siberia. 2016;12(4):28–30. (In Russ).
  2. Rosenkrantz AB, Verma S, Choyke P., et al. Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR. J Urol. 2016;196(6):1613–1618. doi: 10.1016/j.juro.2016.06.079
  3. De Gorski A, Mozer P, Roupret M, et al. En cas de premiere serie de biopsies de prostate, les biopsies prostatiques ciblees par voie transrectale avec fusion echo/IRM ont un meilleur rendement que les biopsies standard pour la detection de cancer significatif dans les prostates > 40 mL. Progres en Urologie. 2014;24(13):813. doi: 10.1016/j.purol.2014.08.068

Declaração de direitos autorais © Burulev A.L., Itskovich I.E., Kakheli M.A., 2021

Creative Commons License
Este artigo é disponível sob a Licença Creative Commons Atribuição–NãoComercial–SemDerivações 4.0 Internacional.

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies